Works matching IS 16624246 AND DT 2014 AND VI 17 AND IP 5/6
Results: 13
Contents Vol. 17, 2014.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. I, doi. 10.1159/000369598
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. X, doi. 10.1159/000362945
- Publication type:
- Article
Title Page / Table of Contents.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 241, doi. 10.1159/000369596
- Publication type:
- Article
Public Health Pharmacogenomics.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 245, doi. 10.1159/000366459
- By:
- Publication type:
- Article
Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 248, doi. 10.1159/000366253
- By:
- Publication type:
- Article
Economic Evaluation of Pharmacogenomics: A Value-Based Approach to Pragmatic Decision Making in the Face of Complexity.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 256, doi. 10.1159/000366177
- By:
- Publication type:
- Article
DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 265, doi. 10.1159/000365895
- By:
- Publication type:
- Article
Assessment of the Pharmacogenomics Educational Environment in Southeast Europe.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 272, doi. 10.1159/000366461
- By:
- Publication type:
- Article
Stakeholder Analysis in Pharmacogenomics and Genomic Medicine in Greece.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 280, doi. 10.1159/000365896
- By:
- Publication type:
- Article
An Index of Barriers for the Implementation of Personalised Medicine and Pharmacogenomics in Europe.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 287, doi. 10.1159/000368034
- By:
- Publication type:
- Article
Cost-Effectiveness of IL28Β Genotype-Guided Protease Inhibitor Triple Therapy versus Standard of Care Treatment in Patients with Hepatitis C Genotypes 2 or 3 Infection.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 306, doi. 10.1159/000365939
- By:
- Publication type:
- Article
Author Index / Subject Index Vol. 17, No. 5-6, 2014.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 320, doi. 10.1159/000369597
- Publication type:
- Article
Personal Genomics in Greece: An Overview of Available Direct-to-Consumer Genomic Services and the Relevant Legal Framework.
- Published in:
- Public Health Genomics, 2014, v. 17, n. 5/6, p. 299, doi. 10.1159/000366175
- By:
- Publication type:
- Article